Health
Whole-Genome Sequencing Is Accurate for Myeloid Cancers – HealthDay News
Prospective sequencing of samples provided new genetic information for 24.8 percent of patients, which changed risk category for 16.2 percent
WEDNESDAY, March 10, 2021 (HealthDay News) — A streamlined whole-genome sequencing approach can provide rapid and accurate genomic profiling for acute myeloid leukemia (AML) or myelodysplastic syndromes, according to a study published in the March 11 issue of the New England Journal of Medicine.
Eric J. Duncavage, M.D., from the Washington University School of Medicine in St. Louis, and colleagues used a streamlined whole-genome sequencing approach to obtain genomic profiles for 263 patients with…
-
Noosa News18 hours agoPill checking to resume in Queensland months after government axed funding
-
Business20 hours agoWhy Austal, Boss Energy, Harvey Norman, and NextDC shares are charging higher today
-
Business22 hours agoASX shares are expensive. Here’s why you should be buying anyway
-
Noosa News22 hours agoNew Queensland Translink app receives scathing reviews as old app is retired